Clinical Trials Browser

Phase 3 × Pancreatic Neoplasms × ruxolitinib × Clear all

NCT02117479 2019-03-26

Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)

Phase 3 Terminated

321 enrolled 13 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02119663 2018-02-13

A Study of Ruxolitinib in Pancreatic Cancer Patients

Phase 3 Terminated

86 enrolled 12 charts

Gastrointestinal

Pancreatic Neoplasms